Login

Global-Dining, Inc. featured an episode with an executive chef and restaurant owner discussing culinary insights, alongside a mention of Apple CEO Tim Cook. 00:10:00

Share On Facebook Share On Twitter

Kozo Hasegawa. CEO at Global-Dining, Inc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Navigating the Potential Recession: Insights from Frazier Financial Advisors
00:10:00
Provider Ownership Transfers and Liability in Medicare/Medicaid
00:10:00
M. Fribourg interviewed by Jean-Marc Sylvestre | Michaël Fribourg, CEO, Chargeurs SACRI:PAR
00:00:00
Timothy Morris - CFO, Head of Business Development, AcelRx Pharmaceuticals Inc
00:10:00
This video explores the key topic of recycling, addressing common questions and concerns surrounding the process.
00:10:00
We use the power of our perspective to help our clients build confident futures|Pat Tomlinson,CEO and President, Mercer Partners L.P
00:10:00
John Elkann on Family Ownership, Leading Exor, and the Legacy of Ferrari and Juventus with Nicolai Tangen
00:10:00
Mission-Driven Investing at The Venture Collective|Nicholas Shekerdemian,Founding Partner,The Venture Collective (TVC)
00:10:00
In order to integrate their supply chain, accounting, and invoicing systems, Crescent Point Energy started using Openinvoice. | Ryan Gritzfeldt, COO, Crescent Point Energy CorpCPG:TOR
00:10:00
Innovative Drug Delivery System for Patients with Swallowing Difficulties: Aquestive Therapeutics' Approach and Medications in Development | Daniel Barber, CEO, Aquestive Therapeutics Inc.
00:10:00
A business update and a new self-service SAS product for creators are delivered by the CEO of Blackbird PLC. | Ian McDonough, CEO, Blackbird PLCFBD:FRA
00:10:00
Radiopharmaceutical Innovations in Cancer Diagnosis |Dr Alan Taylor , Executive Chairma, Clarity Pharmaceuticals Ltd.

© 2017 - Neuhu+